Opioid Withdrawal

American Psychiatric Association Proposes <I>DSM-5</I> Coding Change for Opioid Withdrawal

American Psychiatric Association Proposes DSM-5 Coding Change for Opioid Withdrawal

By

The proposal addresses inappropriate ICD-10-CM coding options for withdrawal from opioids, sedatives, or stimulants.

FDA Grants Priority Review to Lofexidine for Management of Opioid Withdrawal Symptoms

FDA Grants Priority Review to Lofexidine for Management of Opioid Withdrawal Symptoms

By

US WorldMeds announced that the Food and Drug Administration has accepted for Priority Review the New Drug Application for lofexidine to manage the symptoms associated with opioid withdrawal and to facilitate completion of opioid discontinuation treatment.

Tramadol Effective on Opioid Withdrawal Symptoms

Tramadol Effective on Opioid Withdrawal Symptoms

By

The extended-release formulation of tramadol was shown to be as effective as buprenorphine and more effective than clonidine for treating symptoms of opioid withdrawal.

What the Scheduling of Kratom by the DEA Means for Research

What the Scheduling of Kratom by the DEA Means for Research

By

The DEA's plan to list kratom as a Schedule I controlled substance would make researching the possible opioid substitute much more difficult.

Sign Up for Free e-Newsletters